Carmell Corporation (CTCX)
- Previous Close
2.1800 - Open
2.0900 - Bid --
- Ask --
- Day's Range
2.0900 - 2.0900 - 52 Week Range
1.7000 - 13.3100 - Volume
1,520 - Avg. Volume
6,311 - Market Cap (intraday)
40.222M - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
-- - EPS (TTM)
-1.5300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.
www.carmellcosmetics.comRecent News: CTCX
Performance Overview: CTCX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CTCX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CTCX
Valuation Measures
Market Cap
40.22M
Enterprise Value
39.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.63
Enterprise Value/Revenue
12.54
Enterprise Value/EBITDA
-2.60
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-9.93%
Return on Equity (ttm)
-176.39%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-16.88M
Diluted EPS (ttm)
-1.5300
Balance Sheet and Cash Flow
Total Cash (mrq)
2.91M
Total Debt/Equity (mrq)
8.63%
Levered Free Cash Flow (ttm)
-31.19M
Company Insights: CTCX
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: CTCX
Daily – Vickers Top Insider Picks for 02/28/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/27/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/26/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 02/23/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.